Company
United StatesMount Sinai School of Medicine IRB #5 - Board D, Suite 200 New York, NY – FDA Inspections
Inspection records and compliance data for Mount Sinai School of Medicine IRB #5 - Board D in Suite 200 New York, NY. 3 FDA inspections on record, last inspected March 25, 2026.
Company Profile
This profile covers Mount Sinai School of Medicine IRB #5 - Board D based in Suite 200 New York, NY, United States.
FDA Inspection History
- FDA inspections
- 3
- OAI
- 0
- VAI
- 1
- NAI
- 1
- Unclassified
- 1
- Form 483s
- 0
- Warning letters
- 0
First inspected January 31, 2014. Last inspected March 25, 2026.
FDA inspections (3)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| March 25, 2026 | Not classified | Biologics, Human Drugs, Medical Devices & Rad Health | 1312826 |
| March 22, 2018 | NAI | Human Drugs, Medical Devices & Rad Health · Bioresearch Monitoring | 1047499 |
| January 31, 2014 | VAI | Medical Devices & Rad Health · Bioresearch Monitoring | 863841 |
FDA documents
EIRs (1)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
LifeBridge Health, Inc. IRB
Johns Hopkins University School of Medicine IRB
3M Company IRB
Community Health Network IRB
AtlantiCare Regional Medical Center IRB
Philadelphia FIGHT IRB
Sterigenics US LLC
Louisiana State University Health Sciences Center IRB
Georgetown University IRB
Englewood Hospital and Medical Center IRB
Company Information
Name
Mount Sinai School of Medicine IRB #5 - Board D
FEI Number
2431541
Address
345 East 102nd Street, Suite 200 New York, NY 10029-6504, United States
Country
United States
ID: a6b5024c-2050-41a5-a6fd-37dc69601e9f